Mr. Sailer has served as a director of Acurx since October 2018. He is a commercial leader with nearly 30 years of biopharmaceutical experience and currently serves as Senior Vice President, Global Client Solutions at Syneos Health (Nasdaq: SYNH). Previously he was Vice President of Sales and Marketing at Emisphere Technologies (acquired by Novo Nordisk), Vice President of Commercial Operations at New American Therapeutics and at Akrimax Pharmaceuticals, and a member of the executive committee at PDI, a contract commercial organization. He began his career in sales, marketing and sales-management roles in the pharmaceutical and consumer-products divisions of Bristol-Myers Squibb and Bayer Healthcare. Mr. Sailer earned an M.B.A. from Hofstra University and a B.S. in Marketing from Seton Hall University, where he serves as an adjunct graduate professor.